JAMDA
Volume 8, Issue 9 , Pages 607-609 , November 2007

Use of Proton Pump Inhibitors and Other Acid Suppressive Medications in Newly Admitted Nursing Facility Patients

  • Catherine M. Glew, BM, BS, CMD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Catherine M. Glew, BM, BS, CMD, Lehigh Valley Hospital, Center for Healthy Aging, 17th and Chew Streets, PO Box 7017, Allentown, PA 18105-7017.
    • ,
  • Russell J. Rentler, MD

References 

  1. Noble DW. Proton pump inhibitors and stress ulcer prophylaxis: Pause for thought?. Crit Care Med. 2002;30(5):1175–1176
  2. American Society of Health System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;50(4):366–372
  3. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non ICU hospitalized patients. Am J Gastroenterol. 2006;101:2200–2205
  4. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95:3118–3122
  5. Parente F, Cucino C, Gallus S, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: A 1 month survey. Aliment Pharmacol Ther. 2003;17:1503–1506
  6. Martin RM, Dunn NR, Freemantle S, Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: Cohort studies. Br J Clin Pharmacol. 2000;50:366–372
  7. Devlin JW, Welage LS, Olsen KM. Proton pump inhibitor formulary considerations in the acutely ill: Clinical efficacy, safety and economics. Ann Pharmacother. 2005;39:1844–1851
  8. The Medical Letter (Drugs for peptic ulcer). Treat Guidel Med Lett. 2004;2(18):9–12
  9. Thjodleifsson B. Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. Drugs Aging. 2002;19(12):911–927
  10. Yang XY, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947–2953
  11. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhea. J Hosp Infect. 2003;54:243–245
  12. Dial S, Delaney JAC, Barkun AN, Suissa S. Use of gastric acid suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989–2995
  13. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: Cohort and case-control studies. CMAJ. 2004;171(1):33–38
  14. Gardner TB, Robertson DJ. Stress ulcer prophylaxis in non critically ill patients: Less may be more. Am J Gastroenterol. 2006;101:2206–2208

PII: S1525-8610(07)00340-4

doi: 10.1016/j.jamda.2007.07.001

JAMDA
Volume 8, Issue 9 , Pages 607-609 , November 2007

Article Tools